Say Goodbye to Exercise!

Discussion in 'Chit Chat' started by lemmer, Jan 6, 2013.

  1. lemmer

    lemmer

    From what I gathered from the article, it may convert white fat into brown fat, which may aid in weight loss.

    Brown fat is interesting. I have read that brown fat can be stimulated in people who take cold showers.

    There is a school of thought that central heating has taken away our exposure to cold to the point that our brown fat (fat-burning fat) has been neutralized. I've always been skeptical about the idea that there are no alternatives for physical exercise.

    Cold showers are great for stimulating the metabolism, and for men, they are great for your jewels (which need cooler temperatures to be optimal).

    Here is the Wikipedia article:
    http://en.wikipedia.org/wiki/Irisin

    New pill that 'helps you to stay fit without exercise'
    http://www.telegraph.co.uk/health/h...t-helps-you-to-stay-fit-without-exercise.html

    Researchers claim to have created the pill, which they claim provides all the same benefits of exercising without the exertion.

    They claim that a hormone naturally found in muscle cells that triggers the calorie-burning benefits of exercise, may have potential as an obesity-fighting drug.

    The newly identified hormone, called irisin, increases in the body during exercise, boosting energy expenditure and controlling blood glucose levels.

    Medical experts from Harvard Medical School said the new hormone could lead to treatments for obesity, diabetes and even cancer as well as other disorders in which exercise may benefit weaker patients.

    But doctors warned that the pill should not be used to replace exercising.
    Related Articles

    The chemical, named after the Greek messenger goddess Iris, also helps to produce 'healthy' brown fat that burns off weight but largely disappears as we age. It is replaced by "bad" white fat which typically sits around a person's waist.

    Prof Bruce Spiegelman, who led the study, believes harnessing irisin will lead to better therapies for any illness that can be combated by exercise.

    Prof Spiegelman said: "There has been a feeling in the field that exercise 'talks to' various tissues in the body. But the question has been, how?"

    "Whether longer treatments with irisin and/or higher doses would cause more weight loss remains to be determined.

    "The worldwide, explosive increase in obesity and diabetes renders attractive the therapeutic potential of irisin in these and related disorders."

    He added: "Another potentially important aspect of this work relates to other beneficial effects of exercise, especially in some diseases for which no effective treatments exist.

    "The clinical data linking exercise with health benefits in many other diseases suggests that irisin could also have significant effects in these disorders."

    The breakthrough is an important first step in understanding the biological mechanisms that translate physical exercise into beneficial changes throughout the body, both in healthy people and in preventing or treating disease.

    The researchers, whose findings are published online in Nature, said the best effects of exercise on muscle are caused by a protein known as PGC1-alpha.

    They found expression of this molecule in mice stimulated another chemical called FNDC5 that is secreted as irisin in the outer membrane of muscle cells.

    Experiments showed irisin is helps the 'browning' of white fat, which increases energy expenditure and improves resistance to obesity linked diabetes.

    Relatively short treatments of obese mice with irisin improved their glucose control and caused a small amount of weight loss, which the researchers believe highlights its therapeutic potential.

    According to their study, the irisin hormone has direct and "powerful effects" on adipose, or fatty, tissue – subcutaneous deposits of white fat that store excess calories and which contribute to obesity.

    When irisin levels rise through exercise – or when the hormone was injected into mice – it switches on genes that convert white fat into "good" brown fat.

    This is beneficial because brown fat burns off more excess calories than does exercise alone.

    Only a small amount of brown fat is found in adults, but infants have more – an evolutionary echo of how mammals keep themselves warm while hibernating.

    In the wake of findings, there has been a surge of interest in the therapeutic possibilities of increasing brown fat in adults.

    Along with stimulating brown fat development, irisin was shown to improve glucose tolerance, a key measure of metabolic health, in mice fed a high fat diet.

    Prof Spiegelman warned the discovery will not allow people to skip the gym and build muscles by taking irisin supplements, because the hormone does not appear to make muscles stronger.

    “We’re not trying to replace diet and exercise. That is still important," he added.

    The study showed irisin levels increase as a result of repeated bouts of prolonged exercise, but not during short-term muscle activity.

    To test whether increasing irisin alone could mimic exercise benefits, the scientists injected modest amounts into sedentary mice that were obese and pre-diabetic.

    With just 10 days of treatment, the mice had better control of blood sugar and insulin levels – in effect, preventing the onset of diabetes – and lost a small amount of weight.

    Although the weight loss was small, Prof Spiegelman said the hormone may have a greater effect when given for longer periods.

    There were no signs of toxicity or side effects, which was predicted since the researchers limited the increase of irisin to levels typically caused by exercise.

    In part because it is a natural substance and because the mouse and human forms of the protein are identical, Prof Spiegelman said it should be possible to move an irisin-based drug rapidly into clinical testing – perhaps within two years.

    According to the latest government figures, more than 60 per cent of adults in England and a third of 10 and 11 year-olds are overweight.

    Obesity and chronic health conditions such as high blood pressure and diabetes cost Britain £20 billion a year in lost productivity,